levodopa has been researched along with Essential Tremor in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 8 (42.11) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 3 (15.79) | 2.80 |
Authors | Studies |
---|---|
Constantinescu, M; Nassar, M; Schlesinger, I; Sinai, A; Sprecher, E; Zaaroor, M | 1 |
Amami, P; Bocchi, E; Bonvegna, S; Bruzzone, MG; Ciceri, EFM; Cilia, R; Devigili, G; Eleopra, R; Elia, AE; Gasparini, V; Ghielmetti, F; Golfrè Andreasi, N; Grisoli, M; Levi, V; Messina, G; Novelli, A; Piacentini, SHMJ; Prioni, S; Rinaldo, S; Romito, LM; Stanziano, M; Straccia, G; Tringali, G | 1 |
Baumann, CR; Oertel, MF; Stieglitz, LH | 1 |
Warnke, P | 1 |
Rajput, A; Rajput, AH; Rajput, ML; Robinson, CA | 1 |
Ahlskog, JE; Josephs, KA; Klassen, BT; Lee, KH; Matsumoto, JY; Savica, R; Stead, M | 1 |
Akdeniz, M; Yaman, A; Yaman, H | 1 |
Burkhard, PR; Vingerhoets, FJ | 1 |
Ankaralı, H; Gunal, DI; Mollahasanoğlu, A; Ozen Barut, B; Turkmen, C | 1 |
Shweikeh, F; Zahos, PA | 1 |
Ghika, J; Solida, A; Vingerhoets, F | 1 |
Sethi, KD | 1 |
Rajput, A; Rajput, AH; Robinson, CA | 1 |
Ahlskog, JE; Josephs, KA; Matsumoto, JY | 1 |
Linazasoro, G; Magariños, C; Van Blercom, N | 1 |
Pavanni, R; Tan, EK; Tong, J; Wong, MC; Zhao, Y | 1 |
Brown, P; Eusebio, A | 1 |
Lee, SS; Lum, SY; S, FC; Tan, EK | 1 |
Weiner, WJ | 1 |
5 review(s) available for levodopa and Essential Tremor
Article | Year |
---|---|
How best to address these common movement disorders.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Essential Tremor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Practice Guidelines as Topic; Primidone; Propranolol; Tetrabenazine; Tourette Syndrome; Treatment Outcome | 2011 |
[Resistance to treatment in movement disorders].
Topics: Antiparkinson Agents; Apomorphine; Deep Brain Stimulation; Drug Resistance; Essential Tremor; Humans; Levodopa; Movement Disorders; Neurosurgery; Parkinson Disease; Treatment Failure | 2012 |
Tremor.
Topics: Acetates; Amines; Anticonvulsants; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Electromyography; Essential Tremor; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Levodopa; Motor Cortex; Muscle, Skeletal; Parkinson Disease; Posture; Primidone; Randomized Controlled Trials as Topic; Severity of Illness Index; Somatosensory Cortex; Topiramate; Tremor | 2003 |
Paradoxes of functional neurosurgery: clues from basal ganglia recordings.
Topics: Antiparkinson Agents; Basal Ganglia; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Dystonia; Essential Tremor; Globus Pallidus; Humans; Levodopa; Movement Disorders; Neurosurgical Procedures; Parkinson Disease | 2008 |
The initial treatment of Parkinson's disease should begin with levodopa.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors | 1999 |
1 trial(s) available for levodopa and Essential Tremor
Article | Year |
---|---|
Benign tremulous parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Essential Tremor; Family Health; Female; Humans; Levodopa; Longitudinal Studies; Male; Medical Records Systems, Computerized; Middle Aged; Parkinsonian Disorders; Treatment Outcome | 2006 |
13 other study(ies) available for levodopa and Essential Tremor
Article | Year |
---|---|
Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson's Disease: Long-Term Results.
Topics: Aged; Essential Tremor; Humans; Levodopa; Middle Aged; Parkinson Disease; Thalamus; Treatment Outcome; Tremor | 2022 |
Magnetic Resonance-Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early-Stage Tremor-Dominant Parkinson's Disease: A Pilot Study.
Topics: Essential Tremor; Humans; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease; Pilot Projects; Thalamus; Treatment Outcome; Tremor | 2022 |
[Movement Disorders: What Are You Doing? What Can We Do?]
Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Dopamine Agonists; Essential Tremor; Humans; Levodopa; Parkinson Disease | 2020 |
Deep brain stimulation for movement disorders: what counts in the end is the end result.
Topics: Antiparkinson Agents; Deep Brain Stimulation; Essential Tremor; Female; Humans; Levodopa; Male; Parkinson Disease; Subthalamic Nucleus | 2014 |
Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Autopsy; Diagnostic Errors; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Young Adult | 2015 |
Deep brain stimulation in benign tremulous parkinsonism.
Topics: Adult; Aged; Cohort Studies; Deep Brain Stimulation; Disease Progression; Drug Resistance; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Patient Selection; Retrospective Studies; Subthalamic Nucleus; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2011 |
Clinical and cognitive profiles of patients with both Parkinson's disease and essential tremor.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Antiparkinson Agents; Attention; Cognition; Cognition Disorders; Essential Tremor; Executive Function; Female; Humans; Levodopa; Male; Memory; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Primidone; Space Perception | 2013 |
Frameless deep brain stimulation surgery: a community hospital experience.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Data Interpretation, Statistical; Deep Brain Stimulation; Essential Tremor; Female; Follow-Up Studies; Hospitals, Community; Humans; Levodopa; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Treatment Outcome | 2013 |
Acute dopaminergic challenge tests to assess postural/kinetic tremor of different origin: a case report.
Topics: Aged; Antiparkinson Agents; Apomorphine; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Electromyography; Essential Tremor; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Posture; Receptors, Dopamine | 2002 |
Essential tremor course and disability: A clinicopathologic study of 20 cases.
Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive | 2004 |
Three in one: case report supporting different origins of essential and parkinsonian tremors.
Topics: Aged; Antiparkinson Agents; Antithyroid Agents; Combined Modality Therapy; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor; Female; Humans; Hyperthyroidism; Levodopa; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Tremor; Ventral Thalamic Nuclei | 2006 |
Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
Topics: Adult; Antiparkinson Agents; Ataxin-3; Ataxins; Cross-Sectional Studies; Diagnosis, Differential; DNA Mutational Analysis; Drug Resistance; Essential Tremor; Female; Genetic Testing; Genotype; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins; Parkinsonian Disorders; Phenotype; Polymerase Chain Reaction; Repressor Proteins; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Trinucleotide Repeat Expansion; Trinucleotide Repeats | 2007 |
Evidence of increased odds of essential tremor in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index | 2008 |